Peter C. DeMuth
Impact in
- Pharmaceutical Science top 0.5%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Dermatology top 2%
- Dermatology and Skin Diseases
Papers in
- Immunology 18
- Immunotherapy and Immune Responses 16
- Toxin Mechanisms and Immunotoxins 2
- Oncology 10
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 5
- Co-authors
- Paula T. Hammond (10 shared papers)Darrell J. Irvine (10 shared papers)Younjin Min (4 shared papers)Heikyung Suh (2 shared papers)James J. Moon (1 shared paper)Andrew Miller (1 shared paper)Joshua Kramer (2 shared papers)Bonnie Huang (2 shared papers)
- Journals
- Nature Medicine (2 papers)ACS Nano (2 papers)Advanced Healthcare Materials (2 papers)Journal of Clinical Oncology (2 papers)Advanced Materials (2 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Peter C. DeMuth
24 papers receiving 1.1k citations
Peter C. DeMuth's Hit Papers
Peers
Comparison fields: 5 of 82
- Pharmaceutical Science 439
- Dermatology 212
- Immunology 379
- Surfaces, Coatings and Films 116
- Biomaterials 153
Countries citing papers authored by Peter C. DeMuth
This map shows the geographic impact of Peter C. DeMuth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. DeMuth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. DeMuth more than expected).
Fields of papers citing papers by Peter C. DeMuth
This network shows the impact of papers produced by Peter C. DeMuth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. DeMuth. The network helps show where Peter C. DeMuth may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. DeMuth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 232 | |
| 2 | 2012 | 168 | |
| 3 | 2013 | 142 | |
| 4 | 2012 | 139 | |
| 5 | Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial Hit paper breakdown → | 2024 | 124 |
| 6 | 2011 | 109 | |
| 7 | 2010 | 65 | |
| 8 | 2021 | 36 | |
| 9 | 2023 | 34 | |
| 10 | 2023 | 16 | |
| 11 | 2014 | 11 | |
| 12 | 2024 | 10 | |
| 13 | 2024 | 9 | |
| 14 | 2022 | 8 | |
| 15 | 2025 | 7 | |
| 16 | 2013 | 5 | |
| 17 | 2010 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2021 | 2 | |
| 20 | 2024 | 1 |
About Peter C. DeMuth
Peter C. DeMuth is a scholar working on Immunology, Oncology, Pharmaceutical Science, Molecular Biology and Dermatology, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (16 papers), Advancements in Transdermal Drug Delivery (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (5 papers), Advanced Drug Delivery Systems (4 papers), Dermatology and Skin Diseases (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Pharmaceutical Science (439 citations), Dermatology (212 citations), Immunology (379 citations), Surfaces, Coatings and Films (116 citations) and Biomaterials (153 citations). Peter C. DeMuth has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Paula T. Hammond, Darrell J. Irvine, Younjin Min, Heikyung Suh, James J. Moon, Andrew Miller, Joshua Kramer, Bonnie Huang, Dan H. Barouch and Wilfredo F. García-Beltrán. Their work appears in journals such as Nature Medicine, ACS Nano, Advanced Healthcare Materials, Journal of Clinical Oncology and Advanced Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.